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Abstract
Background: To determine the effects of high sucrose diets on vascular reactivity. We hypothesized that similar to high 
fat diets (HFD), HSD feeding would lead to increased adiposity resulting in inflammation and oxidative stress-mediated 
impairment of vasodilation.
Methods: Male Sprague-Dawley rats were fed control chow (Chow), HSD or HFD diets for 6 weeks. The role of 
inflammation and oxidative stress on impaired vasodilation were assessed in isolated mesenteric arterioles.
Results: HSD and HFD induced increased adiposity, oxidative stress and inflammation. HFD rats developed fasting 
hyperglycemia. Both HSD and HFD rats developed impaired glucose tolerance and hyperleptinemia. Nitric oxide (NO)-
mediated vasodilation was significantly attenuated in both HSD and HFD rats but was normalized by treatment with 
antioxidants or anti-inflammatory drugs. Endothelial NO synthase (eNOS) protein expression was not affected by diet. 
Sensitivity to NO was reduced since NOS inhibition attenuated vasodilation in Chow rats but did not further impair 
vasodilation in HSD or HFD rats. Likewise, responsiveness to a NO donor was attenuated in both experimental groups.
Conclusions: Oxidative stress diminishes vasodilatory responsiveness in HSD and HFD rats through ROS-mediated 
scavenging of NO and decreased smooth muscle sensitivity to NO. Inflammation also plays a significant role in the 
impaired vasodilation.
Background
Reactive oxygen species (ROS) have been implicated in
the pathogenesis of many diseases including diabetes [1],
cardiovascular disease, and ischemia reperfusion injury
[2-5]. ROS can be produced through uncoupling of the
electron transport chain or nitric oxide synthase as well
as by NADPH oxidases [6-8]. Hyperglycemia as well as
elevated plasma free fatty acids and triglycerides also
contribute to increased ROS production in addition to
initiating insulin resistance through down-regulation of
insulin signaling pathway intermediates [9-11]
Endogenous antioxidant pathways protect from
increases in ROS, but are often compromised in disease
states. An important constitutive antioxidant pathway is
the breakdown of superoxide anions (O2Žˉ) by superox-
ide dismutase (SOD) to form hydrogen peroxide (H2O2),
which is further converted by catalase or glutathione per-
oxidase to form water and oxygen [12-14].
Increases in the vascular levels of O2Žˉ lead to endothe-
lial dysfunction through scavenging of the endothelial
vasodilator nitric oxide (NO) to form peroxynitrite
(ONOO-) thereby decreasing the bioavailability of NO.
In addition, diminished levels of the essential eNOS
cofactor, tetrahydrobiopterin, results in uncoupling of
eNOS and enhanced O2Žˉ formation leading to further
decreases in NO levels [6-8,11]
Elevated plasma glucose and triglyceride levels, which
can lead to increases in oxidative stress [15], are thought
to be involved in the pathogenesis of impaired vasodila-
tion observed with high caloric intake and resultant
increases in body mass. Increased adiposity is also associ-
ated with chronic inflammation [16,17] and may thus
contribute to impaired vasodilation observed in over-
weight animals. The roles of inflammation and oxidative
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Page 2 of 10stress on responsiveness to the endothelium-dependent
vasodilator acetylcholine (ACh) will be examined in the
present study. The majority of research on the effects of
high fat feeding on vascular function has been carried out
using large conduit arteries such as the aorta from animal
models of established obesity, including rats with high fat
diet-induced obesity. Although these studies are informa-
tive in documenting the end effects of obesity, much less
is known of the nature of vascular derangements in more
modest settings of high caloric intake prior to overt obe-
sity. Moreover, very little research has been conducted
examining the effects of high sucrose feeding, in the
absence of high fat intake, on vascular reactivity. In one
recent study, inactive people who simultaneously
ingested a candy bar and soft drink developed impaired
endothelial function, as evidenced by lower flow-medi-
ated vasodilation, compared to those who ingested the
same meal but underwent a single bout of endurance
exercise the day prior to blood flow measurements [18].
In studies of combined high fat and high sucrose feeding
for 6 months, rats develop impaired aortic endothelial
dependent vasorelaxation that is reversible following a
low-fat complex carbohydrate diet [19]. Other studies
have shown that feeding rats a combined high sucrose
and moderately high fat diet for only 3 days similarly
results in significantly impaired arterial vasorelaxation in
the absence of weight gain [20]. Potential interactions
between high sucrose and high fat in these prior studies
remain unclear. Therefore, the present study was
designed to examine the early effects of high fat or high
sucrose feeding on vasodilation in resistance arterioles
isolated from mildly overweight animals. Moreover, we
examined the potential differential effects of high sucrose
vs. high fat diets to elicit changes in endothelial function.
We hypothesized that feeding rats diets containing high
sucrose or high fat for 6 weeks would produce oxidative
stress and inflammation leading to endothelial dysfunc-
tion and impaired vasodilation in small mesenteric resis-
tance arterioles. Therefore, the goals of the present study
were to 1) demonstrate that rats fed a high sucrose or
high fat diet gain more adiposity compared to Chow fed
controls, 2) show that ROS levels were increased in the
plasma as well as in small mesenteric resistance arterioles
of high sucrose as well as high fat fed rats, 3) determine if
eNOS protein expression is reduced in rats fed either diet
thereby contributing to impaired vasodilation, and 4) test
whether ROS or inflammatory pathways are involved in
the impaired endothelium-dependent vasodilation that
occurs after 6 weeks of high sucrose or high fat intake.
Methods
All protocols and surgical procedures employed in this
study were reviewed and approved by the Institutional
Animal Care and Use Committees of the University of
New Mexico School of Medicine and Arizona State Uni-
versity.
Experimental Groups
Male Sprague-Dawley rats (140-160 g body weight, Har-
lan Industries) were divided into three groups as shown
in table 1. Rats were maintained on the respective diets
for 6 weeks and food was replaced every 2-3 days to pre-
vent spoiling. Animals were exposed to a 12:12 h light
dark cycle and had free access to food and water. Rats
were weighed every week to assess the effect of the diets
on weight gain. At the end of each diet, tail vein blood
samples were collected after a 12-hour overnight fast to
determine plasma triglyceride levels using a CardioCheck
PA analyzer with test strips specific for triglycerides
(Polymer Technology Services, Indianapolis, IN).
Epididymal fat pad mass was determined following the 6-
week feeding protocols to assess the effects of the diet on
body fat content. This fat pad was chosen since it is well
defined and easily extracted thereby minimizing the risk
for experimental bias.
Oral Glucose Tolerance Tests (OGTT)
At the end of the 6-week feeding protocol, rats were food
restricted by providing 4 g/rat of their respective diets at
5 PM the night prior to the OGTT. After an initial tail
vein blood draw at 8 AM the following morning (0 min),
rats were administered an oral dose of 1 g/kg D-glucose
by gavage. Blood samples were taken at 0, 60 and 120
minutes post-glucose administration and whole blood
glucose was measured using a glucose meter (Car-
dioChek PA, Polymer Technology Systems, Inc., India-
napolis, IN).
Table 1: Diet Compositions
Diet Protein (% kcal) Carbohydrates (% kcal) Fat (% kcal) Total kcal/g Source
Chow Diet (Chow) 18.9 57.33 (% sucrose NA) 5 3.4 Cat. No. 2018 
Harlan Teklad
High Sucrose Diet 
(HSD)
20 70 (34.5% sucrose) 10 4.73 Cat. No. D12450B 
Research Diets, Inc
High Fat Diet (HFD) 20 20 (6.8% sucrose) 60 5.24 Cat. No. D12492 
Research Diets, Inc
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Plasma samples were collected by cardiac puncture from
anesthetized rats (sodium pentobarbital, 200 mg/kg i.p.)
in all three groups. The level of lipid peroxidation, as a
measure of oxidative stress, was analyzed using a thiobar-
bituric acid reactive substances (TBARS) assay kit from
OXItek according to the manufacturer's protocol (Cat
No. 0801192, ZeptoMetrix Corp., Buffalo, NY).
Measurement of Plasma Adipokines
Plasma was obtained from deeply anesthetized rats via
cardiac puncture following the 6-week feeding protocol.
Plasma was analyzed by radioimmunoassay using a dual
antibody technique for rat leptin and adiponectin levels
by the Hormone Assay and Analytical Services Core
Facility at Vanderbilt University (Nashville, Tennessee).
Preparation of Experimental Solutions for Isolated Vessel 
Studies
DCF was dissolved in anhydrous dimethyl sulfoxide
(DMSO) at a concentration of 50 μg/ml. Immediately
prior to loading, DCF was mixed with a 20% v/v solution
of pluronic acid in DMSO, and this mixture was diluted
with HEPES buffer to yield a final concentration of 5 μM
DCF and 0.05% pluronic acid. Acetylcholine (ACh; 1.0 M;
Sigma) and phenylephrine (PE; 1.0 M; Sigma) were dis-
solved in deionized water, aliquoted, and frozen (-20˚C)
until use.
Isolation of Mesenteric Resistance Arteries
Rats were anesthetized with sodium pentobarbital (200
mg/kg, i.p.) and a midline laparotomy was performed to
expose and remove the mesenteric arcade. The arcade
was immediately placed in ice-cold HEPES buffer (in
mM: 134.4 NaCl, 6 KCl, 1 MgCl2, 1.8 CaCl2, 10 HEPES,
10 glucose, pH 7.4 with NaOH) pinned out in a Silastic
coated dissection dish, and fifth order mesenteric resis-
tance arterioles (~1 mm length; 80-120 μm, i.d.) were iso-
lated. Isolated arterioles were then transferred to a vessel
chamber (Living Systems, CH-1) filled with HEPES, can-
nulated with glass pipettes, and secured in place with silk
ligature. The vessels were then stretched longitudinally to
approximate in situ length, pressurized to 60 mmHg with
either a fluid filled column or servo-controlled peristaltic
pump (Living Systems Instrumentation, Burlington, VT),
and the chamber placed on a microscope stage for analy-
sis (to be described for each procedure). Vessels were
superfused with warm (37˚C) physiological salt solution
(PSS) containing (in mM): 129.8 NaCl, 5.4 KCl, 0.5
NaH2PO4, 0.83 MgSO4, 19 NaHCO3, 1.8 CaCl2, and 5.5
glucose at a rate of 10 mL/min. The PSS was aerated with
21% O2, 6% CO2, balance N2 gas mixture throughout the
experiments to maintain pH and adequate oxygenation.
Viability was verified prior to each experiment by adding
the vasoconstrictor phenylephrine (PE; 10-6 M) followed
by the endothelium-dependent vasodilator acetylcholine
(ACh; 10-6 M) to the superfusate.
Measurement of Vascular ROS
Vessel chambers were transferred to a Nikon Diaphot 300
microscope equipped with a 10 × fluorescence (FITC)
objective for analysis. Following a 30-minute equilibra-
tion in aerated PSS, vessels were loaded in the dark with
the cell-permeant ROS-sensitive fluorescence indicator,
5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein
diacetate, acetyl ester (DCF; Molecular Probes) in a vessel
chamber attached to a temperature controller (Living
Systems). DCF is oxidized by cytoplasmic peroxynitrite
(ONOO-), hydrogen peroxide (H2O2), and hydroxyl radi-
cals (·OH) to produce a fluorescent product [21-23].
Images were collected prior to DCF loading, for back-
ground, and 50 minutes later using a cooled, digital CCD
camera (SenSys 1400). MetaFluor 4.5 software (Universal
Imaging) was used for processing images. Specificity of
DCF fluorescence as a measure of ROS was verified in
prior experiments in our laboratory [24,25].
Endothelium-Dependent Vasodilation
After equilibration for 30 min, isolated arteries pressur-
ized at 60 mmHg were superfused for 1 hour with either a
control PSS solution or PSS with the addition of antago-
nists. Vessels were then pre-constricted to 50% of resting
inner diameter with PE (Table 2). Vasodilation in
response to increasing concentrations of ACh (10-9 to 10-5
M, 3 min each step) in the superfusate was then deter-
mined by measuring the intraluminal diameter (i.d.)
using a video dimension analyzer (Living Systems, Burl-
ington, VT). Data were digitized using DATAQ A/D soft-
ware for analysis (DATAQ Instruments, Akron, OH).
Additional experiments measuring the effectiveness of
the SOD mimetic, 4,5-Dihydroxy-1,3-benzene-disulfonic
acid (tiron; 10 mM), and catalase (1200 U/mL) at restor-
ing ACh-induced vasodilation were performed.
Responses to ACh in the presence of the synthetic man-
ganese-porphyrin complex, chloro[[2,2'-[1,2-ethanediyl-
bis[(nitrilo-κN)methylidyne]]bis[6-methoxyphenolato-
κO]]]-manganese (EUK-134; 10 μM; Cayman Chemical
Company, Ann Arbor, MI), were also examined. This
compound is an SOD mimetic with enhanced catalase
activity [26]. Inhibition of nitric oxide synthase, using 100
μM Nω-nitro-L-arginine (LNNA; Sigma), was performed
to determine the role of NO in ACh-induced vasodila-
tion. Further studies to assess the combined effects of
LNNA and tiron and catalase or EUK-134 on vasodilatory
responses were performed. Vascular reactivity in the
presence of the hydrogen peroxide scavenger catalase
(1200 U/mL) or an inhibitor of cyclooxygenase (COX)
(indomethacin, 10 μM) was also examined. Vessels were
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PSS (in mM/L: 129.8 NaCl, 5.4 KCl, 0.5 NaH2PO4, 0.83
MgSO4, 19.0 NaHCO3, 5.5 glucose, and 3.0 EGTA) to
obtain the passive inner diameter from which total con-
striction and subsequent percent vasodilation were calcu-
lated.
Vascular Smooth Muscle Sensitivity to NO
After equilibration for 30 min, isolated arteries pressur-
ized at 60 mmHg were superfused for 1 hour with PSS.
Vessels were then pre-constricted to 50% of resting inner
diameter with increasing concentrations of PE. Vasodila-
tion in response to the NO donor sodium nitroprusside
(10-11 to 10-3 M, 3 min each step) in the superfusate was
then determined by measuring the intraluminal diameter
(i.d.) using a video dimension analyzer (Living Systems,
Burlington, VT). Vessels were subsequently superfused
for 30 min with calcium-free PSS (in mM/L: 129.8 NaCl,
5.4 KCl, 0.5 NaH2PO4, 0.83 MgSO4, 19.0 NaHCO3, 5.5
glucose, and 3.0 EGTA) to obtain the passive inner diam-
eter from which total constriction and subsequent per-
cent vasodilation were calculated. Data were digitized
using DATAQ A/D software for analysis (DATAQ Instru-
ments, Akron, OH).
Western Blots for Endothelial Nitric Oxide Synthase (eNOS)
Mesenteric arteries were isolated and snap-frozen in liq-
uid nitrogen. Frozen arteries were homogenized in ice-
cold Tris-HCl homogenization buffer containing 10 mM
Tris (pH 7.6), 1 mM EDTA, 1% triton X-100, 0.1% Na-
deoxycholate, 0.03% protease inhibitor cocktail (Sigma
P2714), and 1 mM phenylmethanesulfonyl fluoride
(PMSF) using a ground glass homogenizer. Homogenates
were then spun at 4000 g for 10 min at 4˚C to remove
insoluble debris. Protein concentration in the superna-
tant was analyzed using the Bradford method (Bio-Rad,
Hercules, CA). Tissue sample proteins (25 μg/lane) were
resolved by 7.5% Tris-HCl sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) (Bio-Rad,
Hercules, CA). The separated proteins were then trans-
ferred to Immuno-Blot polyvinylidene difluoride (PVDF)
membranes (Bio-Rad, Hercules, CA). The membranes
were subsequently incubated in blocking buffer (100 ml
Tween/Tris-buffered saline (TTBS), 3% BSA, 5% nonfat
dry milk) for 1 hr at room temperature. Following washes
in TTBS, PVDF membranes were incubated overnight at
4˚C with mouse monoclonal antibody specific for eNOS
(1:2500; Cat. 610296; BD Transduction Laboratories, San
Jose, CA) and rabbit polyclonal antibody to β-actin as a
loading control (1:10,000; Cat. Ab8227; AbCam, Cam-
bridge, MA). Membranes were then washed in TTBS and
incubated with anti-mouse and anti-rabbit horseradish
peroxidase-conjugated secondary antibodies (1:5000,
Cat. PI-2000 and PI-1000; Vector Laboratories, Burl-
ingame, CA) for 1 hr at room temperature followed by
washes in Tris-buffered saline (TBS) and a 1 min expo-
sure to Pierce enhanced chemiluminescence western
blotting substrate (Thermo Scientific, Rockford, IL).
Immunoreactive bands were visualized by exposure to x-
ray film (Kodak X-OMAT, Thermo Fisher Scientific,
Pittsburgh, PA). The developed films were analyzed using
ImageJ software (NIH) and eNOS protein levels were
normalized to β-actin.
Statistics
Data are expressed as means ± SEM. Analysis of variance
(ANOVA) was used to compare physical and biochemical
data (Table 2) as well as eNOS protein expression data
within and between groups. Data from the oral glucose
tolerance test were analyzed using repeated measures
ANOVA. Percent vasodilation to ACh and SNP were cal-
culated as the percent reversal of tone elicited by phe-
nylephrine as well as inherent myogenicity. This is
determined by measuring the difference in intraluminal
diameter observed at each concentration of ACh or SNP
vs. the inner diameter observed in a calcium free solution
designed to eliminate all tone. Percentage data were arc-
sine transformed to approximate normal distribution
Table 2: Physical and Biochemical Parameters
Parameter Chow HSD HFD n
Initial Body Weight (g) 151.5 ± 1.68 151.3 ± 1.35 150.6 ± 1.58 44-47
Final Body Weight (g) 336.6 ± 3.63 359.7 ± 3.84* 371.3 ± 4.00*# 44-47
6 Week Weight Gain (g) 185.1 ± 3.62 208.5 ± 4.10* 220.8 ± 4.37*# 44-47
Epididymal Fat Pad Mass (g) 2.72 ± 0.15 4.00 ± 0.27* 5.61 ± 0.38*# 9-10
Plasma Triglycerides (mg/dL) 51.50 ± 0.92 95.00 ± 8.11* 52.11 ± 2.11# 9-10
Plasma Leptin (ng/mL) 1.18 ± 0.25 2.15 ± 0.36* 3.50 ± 0.54* 5-7
Plasma Adiponectin (μg/mL) 18.17 ± 2.41 16.31 ± 2.77 17.32 ± 1.27 5-13
Plasma TBARS (nM/L) 21.29 ± 2.20 32.54 ± 2.56* 29.88 ± 1.59* 9-10
Data expressed as means ± SEM; *p < 0.05 from Chow; #p < 0.05 from HSD.
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Where significant effects were indicated by ANOVA,
individual groups were compared using Student-New-
man-Keuls post hoc analysis. A probability of ≤ 0.05 was
accepted as statistically significant for all comparisons.
Results
Diet
Both HSD and HFD rats gained significantly more weight
and epididymal fat pad mass over the course of the 6-
week feeding protocol compared to Chow fed rats, with
the HFD rats gaining the most (Table 2). This represents
an overall weight gain that was 11.2% greater than Chows
in the HSD group and 16.2% greater in the HFD group.
Despite the significant increases in weight by rats in each
experimental feeding protocol, according to Lee's Index
of obesity ((1/3(body weight(g)/nasoanal length (mm)) ×
10000); data not shown) it was not sufficient to classify
the animals as obese, but rather, a mild increase in body
weight was developed.
Plasma Triglycerides and Whole Blood Glucose 
Measurements
Plasma triglyceride levels were significantly elevated in
the HSD group compared to Chow and HFD rats (Table
2). Fasting glucose levels were significantly elevated in the
HFD fed rats (Figure 1A). Sixty minutes after an oral glu-
cose dose, plasma glucose levels remained above baseline
in both HFD and HSD fed rats but returned to fasting lev-
els in the Chow fed controls. By 120 minutes, glucose lev-
els in the HFD fed rats returned to fasting levels and were
not significantly different from Chows, whereas levels in
HSD rats remained significantly elevated from initial
baseline glucose concentrations.
Levels of Circulating Adipokines
Plasma leptin levels, which are positively correlated with
adiposity, were elevated in both HSD and HFD rats (Table
2). There were no significant differences in plasma adi-
ponectin levels between the three groups of rats (Table 2).
Measurement of Plasma and Vascular ROS
Plasma TBARS, a measure of whole animal oxidative
stress, were significantly elevated in both the HSD and
HFD fed rats compared to Chow fed controls (Table 2).
Levels of ROS (ONOOˉ, ŽOH, and H2O2) assessed by
DCF fluorescence were also significantly elevated in mes-
enteric resistance arterioles isolated from both HSD and
HFD fed rats compared to Chow fed controls (Figure 1B).
ROS-Mediated Vascular Dysfunction
ACh-induced vasodilation was significantly impaired in
mesenteric resistance arterioles from both HSD and HFD
fed rats compared to Chow fed controls (Figure 2). Incu-
bation with the NOS inhibitor, LNNA (100 μM) had no
significant effect on ACh-mediated vasodilation in arter-
ies from HSD and HFD fed rats whereas Chow fed rats
demonstrated significant attenuation of relaxation (Fig-
ures 3, 4, 5). These data demonstrate that ACh-mediated
vasodilation is impaired following high calorie feeding
and that this impairment is associated with a reduced
vasodilatory role of NO. The addition of tiron (10 mM)
and catalase (1200 U/mL) or EUK-134 (10 μM) had no
significant effect on ACh-induced vasodilation in arteries
from Chow fed control rats (Figure 3). In contrast, tiron
and catalase were effective at normalizing vasodilatory
responses in vessels from both HSD and HFD fed rats
(Figures 4 &5), whereas EUK-134 only restored vasodila-
tion in vessels from HFD fed rats (Figure 5). There were
no significant differences in vasodilation responses in
untreated and EUK-134 treated vessels from HSD rats
(Figure 4). The combined effects of LNNA and EUK-134
or tiron and catalase were also assessed. The combined
incubation of arteries from Chow fed rats did not result
in further attenuation of vasodilation compared to LNNA
treatment alone (Figure 3). In contrast, the combined
treatment of arteries from HSD and HFD rats with
LNNA and tiron and catalase resulted in significantly
blunted vasodilation (Figures 4 &5). Incubation of arter-
ies with LNNA and EUK-134 from HSD rats also signifi-
cantly blunted vasodilation (Figure 4), but produced no
further impairment of vasodilation in arteries from HFD
rats compared to untreated HFD arteries (Figure 5). Incu-
bation of arteries with the H2O2 scavenger catalase signif-
Figure 1 Panel A: Whole blood glucose levels during an oral glu-
cose tolerance test in Chow (n = 5-7), HSD (n = 5), and HFD (n = 5) 
fed rats. Rats were food restricted by providing 4 g/rat of their respec-
tive diets at 5 PM the night prior to the OGTT. At 8 am the following 
morning, rats were administered an oral bolus of glucose (1 g/kg D-
glucose) by gavage immediately following the initial glucose sample 
(0 min). Glucose levels returned to baseline by 120 mins in the Chow 
and HFD fed rats but remained elevated in HSD fed rats. Data ex-
pressed as means ± SEM. *p < 0.05 vs. corresponding time point in 
Chows; #p < 0.05 vs. initial blood glucose level (time 0); §p < 0.05 vs. 
corresponding level at 60 mins. Panel B: Measurement of oxidative 
stress in isolated mesenteric resistance arterioles from rats following 
the 6-week feeding protocol. 5-(and-6)-chloromethyl-2',7'-dichlorodi-
hydrofluorescein diacetate, acetyl ester (DCF) fluorescence (average 
gray scale values above background) in isolated mesenteric resistance 
arteries from Chow (n = 6), HSD (n = 5) and HFD (n = 5) fed rats. Data 
are expressed as means ± SEM. *p ≤ 0.05 vs. Chow fed controls
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supporting a normal vasodilatory role of H2O2 in this
group (Figure 6A). In contrast, incubation of arteries
from HSD rats with catalase normalized ACh-mediated
vasodilation but did not improve vasodilation of arteries
from HFD rats (Figures 6B &6C). Inhibition of COX
using indomethacin significantly impaired vasodilation in
arteries from Chow rats, but completely normalized
vasodilation in arteries from HSD rats and mildly
improved vasodilation in arteries from HFD rats (Figures
6A-C).
Vascular Smooth Muscle Sensitivity to Nitric Oxide (NO)
Compared to Chow fed rats, those fed either HSD or
HFD developed significantly impaired vascular smooth
Figure 2 Endothelium-dependent vasodilation in isolated small 
mesenteric arterioles from rats fed either Chow, HSD, or HFD (n = 
6-8 per group). Vasodilatory responses to acetylcholine were mea-
sured in pre-constricted arteries (50% of resting inner diameter). There 
were no significant differences in pre-constricted diameters between, 
or within, groups (Table 2). Compared to Chow fed controls, arteries 
from HSD and HFD rats exhibited significantly attenuated vasodilation. 
Data are expressed as means ± SEM. *p ≤ 0.05 vs. Chow controls.
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Figure 3 Acetylcholine-mediated vasodilatory responses in iso-
lated mesenteric resistance arteries from Chow fed rats. Vasodila-
tory responses to acetylcholine (ACh) were measured in the presence 
and absence of the NOS inhibitor Nω-nitro-L-arginine (LNNA; 100 μM) 
in small mesenteric arteries (n = 6-8). Arteries were exposed to LNNA in 
the lumen and superfusate prior to pre-constriction with phenyleph-
rine to 45-50% resting inner diameter. Vasodilatory responses to ace-
tylcholine (ACh) were also measured in the presence and absence of 
antioxidants (n = 4-5). For these studies, arteries were pre-constricted 
as previously described. Treated arteries were pre-exposed to the ROS 
scavengers 4,5-Dihydroxy-1,3-benzene-disulfonic acid (tiron; 10 mM) 
and catalase (1200 U/mL) or EUK-134 (10 μM). Separate arteries were 
exposed to the nitric oxide synthase inhibitor LNNA (100 μM) or LNNA 
with the addition of EUK-134 or tiron and catalase. The Chow control 
data (dotted line) are repeated from figure 2 for comparison. Data are 
expressed as means ± SEM. *p ≤ 0.05 vs. controls; †p < 0.05 vs. EUK-134 
or T+C only.
Acetylcholine [M]
0.0001 0.001 0.01 0.1 1 10 100
%
 C
al
ci
u
m
 F
re
e 
D
ia
m
et
er
20
40
60
80
100
120
CHOW CON 
CHOW LNNA 
CHOW EUK 
CHOW LNNA+ EUK 
*
* * *
*† † * † *
†*
* † * †
Acetylcholine [M]
0.0001 0.001 0.01 0.1 1 10 100
%
 C
al
ci
u
m
 F
re
e 
D
ia
m
et
er
20
40
60
80
100
120
CHOW CON 
CHOW LNNA 
CHOW T+C 
CHOW LNNA+ T+C 
†*† † † † * * * *
*
***
*
Figure 4 Acetylcholine-mediated vasodilatory responses in iso-
lated mesenteric resistance arteries from HSD fed rats. Vasodilato-
ry responses to acetylcholine (ACh) were measured in the presence 
and absence of the NOS inhibitor Nω-nitro-L-arginine (LNNA; 100 μM) 
in small mesenteric arteries (n = 6-8). Arteries were exposed to LNNA in 
the lumen and superfusate prior to pre-constriction with phenyleph-
rine to 45-50% resting inner diameter. Vasodilatory responses to ace-
tylcholine (ACh) were also measured in the presence and absence of 
antioxidants HSD (n = 4-9). For these studies, arteries were pre-exposed 
to the ROS scavengers 4,5-Dihydroxy-1,3-benzene-disulfonic acid 
(tiron; 10 mM) and catalase (1200 U/mL) or EUK-134 (10 μM). Separate 
arteries were exposed to the nitric oxide synthase inhibitor LNNA (100 
μM) or LNNA with the addition of EUK-134 or tiron and catalase. The 
HSD control data (dotted line) are repeated from figure 2 for compari-
son.Data are expressed as means ± SEM. *p ≤ 0.05 HSD controls vs. 
Chow controls; #p ≤ 0.05 vs. HSD controls; †p < 0.05 vs. HSD EUK-134 
or T+C only; §p ≤ 0.05 vs. HSD LNNA only.
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Figure 5 Acetylcholine-mediated vasodilatory responses in iso-
lated mesenteric resistance arteries from HFD fed rats. Vasodilato-
ry responses to acetylcholine (ACh) were measured in the presence 
and absence of the NOS inhibitor Nω-nitro-L-arginine (LNNA; 100 μM) 
in small mesenteric arteries (n = 6-8). Arteries were exposed to LNNA in 
the lumen and superfusate prior to pre-constriction with phenyleph-
rine to 45-50% resting inner diameter. Vasodilatory responses to ace-
tylcholine (ACh) were also measured in the presence and absence of 
antioxidants (n = 5-8). For these studies, arteries were pre-exposed to 
the ROS scavengers 4,5-Dihydroxy-1,3-benzene-disulfonic acid (tiron; 
10 mM) and catalase (1200 U/mL) or EUK-134 (10 μM). Separate arteries 
were exposed to the nitric oxide synthase inhibitor LNNA (100 μM) or 
LNNA with the addition of EUK-134 or tiron and catalase. The HFD con-
trol data (dotted line) are repeated from figure 2 for comparison. Data 
are expressed as means ± SEM. *p ≤ 0.05 HFD controls vs. Chow con-
trols; #p ≤ 0.05 vs. HFD controls; †p < 0.05 combined HFD LNNA + EUK-
134 or T+C vs. HFD EUK-134 or T+C only; §p ≤ 0.05 combined HFD 
LNNA T+C vs. HFD LNNA only.
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Page 7 of 10muscle sensitivity to NO as indicated by blunted
responses to the NO donor sodium nitroprusside (Figure
7).
Western Blots for Endothelial Nitric Oxide Synthase (eNOS)
Protein concentration of eNOS in mesenteric arteries was
not significantly different between groups (Figure 8).
Discussion
The major findings of this study are that 6 weeks of high
sucrose or high fat feeding results in increased body mass
and adiposity (Table 2) concomitant with increased oxi-
dative stress and impaired vasodilation, although the
mechanism of impaired vasodilation differed for each
group. Vasodilation of arteries from Chow fed rats is
dependent on NO as well as H2O2 (Figures 3 and 6). Feed-
ing rats either HSD or HFD results in diminished vascu-
lar smooth muscle sensitivity to NO (Figure 7).
Vasodilation is further impaired in rats fed HSD as a
result of increases in H2O2 which acts to oppose vasodila-
tion (Figures 1, 4 &6). In contrast, the findings of this
study implicate O2Žˉ-mediated scavenging of NO to form
ONOO- in arteries from rats fed HFD (Figures 1 &5).
Feeding rats a HSD diet alone elicited hypertriglyceri-
demia (Table 2), impaired glucose tolerance (Figure 1A),
hyperleptinemia (Table 2), enhanced oxidative stress
(Table 2 & Figure 1B) and impaired acetylcholine-medi-
ated vasodilation (Figure 2), which are characteristics of
metabolic syndrome and pre-diabetes. Animals on the
HFD gained more adiposity compared to the HSD rats
(Table 2) and demonstrated further characteristics of
metabolic syndrome as they developed fasting hypergly-
cemia (Figure 1A) in addition to hyperleptinemia (Table
2), oxidative stress (Table 2 & Figure 1B), and impaired
acetylcholine-induced vasodilation (Figure 2). These sig-
nificant alterations in oxidative stress and vascular reac-
tivity demonstrate that vascular dysfunction occurs well
before the development of obesity and that different diets
can have varying effects on biochemical parameters and
vascular reactivity in rats.
Elevated plasma glucose, free fatty acids and triglycer-
ides contribute to increased ROS production [9-11]. Pre-
vious studies have shown that feeding obesity-prone
Sprague-Dawley rats a moderately high fat diet (32%
kcal% as fat) for 16 weeks results in elevated TBARS and
O2Žˉ in aorta [27]. Similarly, our studies demonstrate
increased fasting glucose in the HFD rats (Figure 1A) and
plasma triglycerides in the HSD rats (Table 2) with both
groups of rats developing elevated TBARS and DCF fluo-
rescence, indicative of vascular ROS (Table 2 & Figure
1B).
Multiple oxidative stress pathways can potentially lead
to decreases in NO bioavailability and therefore, a reduc-
tion in vasodilatory responses. A direct pathway occurs
Figure 6 Acetylcholine-mediated vasodilatory responses in iso-
lated mesenteric resistance arteries following inhibition of COX 
(100 μM indomethacin) or hydrogen peroxide (1200 U/mL cata-
lase). Panel A: Data from Chow-fed rats. Panel B: Data from HSD-fed 
rats. Panel C: Data from HFD-fed rats. All data expressed as means ± 
SEM. *p < 0.05 catalase vs. respective untreated control (CON); #p < 
0.05 indomethacin vs. respective untreated control (CON).
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Page 8 of 10by O2Žˉ-induced scavenging of endothelial-derived NO
to form peroxynitrite (ONOO-) [6,7]. Another mecha-
nism involves the uncoupling of eNOS as a result of
diminished levels of the essential eNOS cofactor, tetrahy-
drobiopterin, resulting in enhanced O2Žˉ formation and
further decreases in NO levels [6-8,11]. Furthermore,
ONOO- itself can oxidize and deactivate tetrahydrobiop-
terin [28]. Moreover, H2O2, produced from the break-
down of O2Žˉ, is reported to exhibit vasodilatory or
vasoconstrictor effects depending on the concentration
or tissue examined [29-31]. Since the observed increase
in oxidative stress in HSD and HFD rats may directly
affect blood vessel reactivity or impact NO bioavailability,
the effects of oxidative stress on endothelium-mediated
vasodilation were measured (Figures 3, 4, 5, 6).
Data from the present study demonstrate that high
sucrose and high fat feeding result in significantly attenu-
ated endothelium-dependent vasodilation compared to
Chow-fed controls (Figure 2). In Chow-fed rats, ACh-
mediated vasodilation appears to rely on NO since the
NOS inhibitor LNNA nearly abolished the vasodilatory
response (Figure 3). In contrast, inhibition of NOS caused
no further impairment of vasodilation in HSD and HFD
fed rats (Figures 4 &5). These data suggest that ROS may
be involved in the scavenging of NO in these animals as
eNOS protein expression levels were not significantly dif-
ferent in the experimental groups compared to Chow fed
rats (Figure 8). Further studies demonstrated that arteries
from HSD and HFD rats have impaired vascular smooth
muscle sensitivity to NO contributing to the impaired
ACh-mediated vasodilation (Figure 7). Therefore, it is
evident that the residual response to ACh following high
calorie feeding is NO-independent and likely involves
other endothelium-dependent vasodilatory pathways.
Since the observed increase in oxidative stress in HSD
and HFD rats may impact NO bioavailability, the effects
of oxidative stress on endothelium-mediated vasodilation
were measured (Figures 3, 4, 5, 6). ACh-mediated vasodi-
lation responses in arteries from HFD rats were greatly
attenuated across a broad range of ACh doses and were
normalized by the inhibition of ROS using either tiron
and catalase or EUK-134 (Figure 5). In contrast, vasodila-
tion of arteries from HSD rats was impaired at only high
doses of ACh which likewise demonstrated improved
vasodilation in the presence of tiron and catalase but not
EUK-134 (Figure 4). These data illustrate that oxidative
stress plays a role in the limitation of ACh-mediated
vasodilation in HSD and HFD rats with only modest
increases in adiposity. Oxidative stress is similarly
involved in the impaired vasodilatory responses of aortic
rings and renal arterioles from alloxan-induced diabetic
rabbits [32]. Impaired endothelium-dependent vasodila-
tion, as occurs in coronary artery diseases, has likewise
been linked with increased oxidative stress since adminis-
tration of the antioxidant vitamin C improved the
response in humans [33]. Similarly, Zucker obese rats
exhibit attenuated responses to ACh in isolated coronary
as well as middle cerebral arteries [34,35]. Moreover,
diminished ACh-mediated vasorelaxation in thoracic
aorta from insulin resistant rats has been observed [36].
To test whether impaired vasodilation in arteries from
HSD and HFD is due to an interaction of ROS and NO,
vessels from each group were incubated in the presence
of both the NOS inhibitor LNNA and the ROS scavengers
tiron and catalase or EUK-134. Data from these studies
demonstrate that impaired vasodilatory responses
Figure 7 Vasodilatory responses to the NO donor sodium nitrop-
russide in isolated mesenteric arteries from Chow, HSD and HFD 
rats. Data expressed as means ± SEM. *p ≤ 0.05 Chow vs. HSD; #p ≤ 0.05 
Chow vs. HFD.
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Figure 8 Immunostaining of endothelial nitric oxide synthase 
(eNOS) in mesenteric artery homogenates from Chow (C), HSD 
(HS), and HFD (HF) fed rats. Densitized values of the immunoblot 
were normalized to β-actin protein concentration and are expressed 
as a ratio (mean ± SEM). Inset: representative blot of eNOS and β-actin 
in isolated rat mesenteric arteries from rats in all three treatment 
groups. n = 5-6 per group. Data are not significantly different.
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Page 9 of 10recorded in arteries from HSD rats is at least in part
mediated by reduced NO bioavailability as the combined
treatment nearly abolished vasodilation (Figure 4). Simi-
lar results were observed in arteries from HFD rats
treated with LNNA and tiron and catalase, suggesting
that ROS may also reduce the bioavailability of NO in
these vessels (Figure 5). However, superfusion of arteries
with LNNA and EUK-134 did not normalize vasodilation
in arteries from these rats (Figure 5). This apparent dis-
crepancy may be due to the different mechanisms of
action of each of these ROS scavengers.
Since H2O2 is known to exert both vasodilatory and
vasoconstrictor properties, we examined the role of H2O2
by exposing arteries to catalase in the absence of superox-
ide dismutase mimetics. In arteries from HFD rats, this
exposure did not improve vasodilation (Figure 6C)
whereas the combined superoxide dismutase mimetics
and catalase were successful at normalizing vasodilation
(Figure 5). This suggests that in HFD vessels, elevated
O2Žˉ may be responsible for scavenging of NO resulting
in the production of ONOOˉ. In contrast, arteries from
HSD fed rats demonstrate only a mild improvement in
ACh-mediated vasodilation in the presence of tiron and
catalase but no effect of EUK-134 (Figure 4). Since inhibi-
tion of H2O2 alone normalized vasodilation in this group
(Figure 6B), this supports a role for H2O2 as a vasocon-
strictor following HSD feeding. DCF can be oxidized by
both ONOOˉ and H2O2 resulting in increased fluores-
cence as we observed in arteries from HSD and HFD rats
(Figure 1B). Our data also demonstrate a physiological
role of H2O2 in vasodilatory responses of arteries from
Chow rats (Figure 6A), that has been described by others
[29-31].
We also observed a differential role of COX products
between the different feeding regimens. In Chow rats,
COX inhibition blunted ACh-mediated vasodilation (Fig-
ure 6A). In contrast, indomethacin normalized vasodila-
tion in arteries from HSD rats suggesting a switch to
vasoconstrictor COX products following high sucrose
feeding (Figure 6B) that was only minimally present in the
HFD group (Figure 6C). Thus, the profile of COX-derived
vasoactive products may be altered by diet.
In summary, our data demonstrate that feeding rats
either a high fat or high sucrose diet results in the devel-
opment of oxidative stress as well as impaired vasodila-
tion. The data highlight the importance of the type of diet
as it can produce divergent effects on vascular reactivity
pathways despite both groups developing increased body
mass, adiposity and oxidative stress. Although rats in the
HSD fed group develop similar levels of oxidative stress
as observed in the HFD rats, the impaired vasodilation is
not as severe and the mechanisms of impaired vasodila-
tion are divergent. In the HFD group, the impaired vaso-
dilation appears to be mediated in part by O2Žˉ
scavenging of NO. In contrast, H2O2 is implicated in the
impaired vasodilatory responses in vessels from HSD
rats. In conclusion, the impaired vasodilatory responses
to acetylcholine in rats fed either HSD or HFD are medi-
ated by ROS scavenging of NO, impaired smooth muscle
sensitivity to NO as well as by inflammatory factors.
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